We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Diabetes care leader Novo Nordisk has completed a definitive agreement to sell
its entire shareholding in Ferrosan to a holding company, making the Altor 2003
Fund the new majority shareholder in the Ferrosan group.
Massachusetts Senate President Robert Travaglini (D) has introduced a bill that
would endorse human embryonic stem cell research in the state and void a 30-year-old
law that requires such research to be approved by county district attorneys,
The New York Times reports.
Cerus will immediately pay $34.5 million to Baxter Capital and provide a promissory
note for $4.5 million, payable with interest in December 2006, to end a legal
battle.
Although both paid and unpaid consulting arrangements between NIH scientists
and private industry will end under the agency's new ethics rule, some observers
believe informal communications should continue while others predict a bleak
future for public-private partnerships.
The FDA has posted briefing information on its Feb. 16-18
joint advisory committee meeting to examine risk-benefit considerations for
Cox-2 selective nonsteroidal anti-inflammatory drugs and related agents.
Oklahoma has jumped on the drug importation bandwagon, announcing it is weighing
a plan to allow its residents to buy prescription drugs from overseas.
A government panel has recommended that all college freshmen who live in dorms
receive a new meningitis vaccine that lasts years longer than the old one and
prevents people from being carriers of the bacteria.